International

GOP Tech Plan Takes Aim at H1-B Visas, Taxes, and Patent Law

In a speech announcing an "Innovation Agenda" for the new Congress, the senator also touted his ties to President Trump, and said he would act as bridge between the tech industry and the White House—a role that could be critical given the open antagonism that exists between Trump and many corners of Silicon Valley. [...]

By |2017-09-07T18:43:52+05:30April 26th, 2017|India, International|0 Comments

Arista Prevails against Cisco in Latest Patent Ruling

In a back-and-forth case between Cisco and Arista related to patents, the U.S. Customs and Border Protection (CBP) agency on Friday sided with Arista. CBP completed its review related to the U.S. International Trade Commission Investigation No. 337-TA-944 (Case ‘944) and once again ruled that Arista’s redesigned products do not infringe Cisco patents. Arista [...]

By |2017-09-07T19:17:35+05:30April 11th, 2017|Copyright, International|0 Comments

When Today’s Pizza Meets Ancient Law

One of the most challenging exercises in the IP world is to imagine an alternative framework for fashioning the law. In the IP word where international agreements homogenize the way that we view intangible assets, it is refreshing sometimes to ponder, how things might be conceived differently. The review described the Jewish law as, [...]

By |2017-09-08T10:23:52+05:30April 3rd, 2017|International, IP Basics|0 Comments

GOP Tech Plans Aims at H1-B Visas, Taxes, and Patent Law

Senator Orrin Hatch unveiled an ambitious agenda to boost the US tech industry which included proposed reforms to contentious issues like immigration and corporate tax policy. In a speech announcing an “innovation agenda” for the new congress, the senator also touted his ties with the president trump and said he would act as a [...]

By |2017-09-08T10:40:21+05:30March 30th, 2017|International, Patent|0 Comments

Regeneron, Sanofi-Aventis sue for declaration that dermatitis treatment Dupixent doesn’t infringe Amgen patent

On Monday, March 20th, American pharmaceutical companies Sanofi-Aventis US, a subsidiary of France-based Sanofi S.A. (NYSE:SNY), and Regeneron (NASDAQ:REGN) were listed as plaintiffs in a suit filed to seek declaratory judgment of non-infringement of a patent held by American biopharma firm Amgen (NASDAQ:AMGN). Sanofi-Aventis and Regeneron are hoping to protect their market interest in a treatment developed to help patients [...]

By |2017-09-08T10:41:28+05:30March 30th, 2017|International, Patent|0 Comments

3D Printing In Africa: Huge Benefit or Big IP Threat?

The tool with an ability to print enormous structures across a wide array of trans-disciplinary applications could arguably be Africa’s largest 3D printer. It was unveiled this month. Timothy Momsen, a masters student whose studies related to additive manufacturing techniques, took roughly a year to construct the printer which consumed materials close to R75000 [...]

By |2017-09-08T11:08:08+05:30March 25th, 2017|IP Basics, International|0 Comments
Go to Top